A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®

Peer Review reports

Original Submission
19 May 2021	Submitted	Original manuscript
2 Aug 2021	Reviewed	Reviewer Report - Alexander Gough
26 Aug 2021	Author responded	Author comments - Benjamin Speich
Resubmission - Version 2
26 Aug 2021	Submitted	Manuscript version 2
9 Sep 2021	Reviewed	Reviewer Report - Alexander Gough
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
15 Sep 2021	Editorially accepted
21 Oct 2021	Article published	10.1186/s13063-021-05664-0

Back to article page